The new external drug for the treatment of psoriasis based on inhibition of serine proteases
Background: Psoriasis is a chronic inflammatory immune-mediated disease characterized by an increased rate of keratinocyte division. The results of recent studies have made it possible to establish that the cytokines of the IL-36 family occupy a significant place in the initiation and regulation of...
Guardado en:
Autores principales: | Alexander S. Zhukov, Evgeny R. Zharun, Vladislav R. Khairutdinov, Alexey V. Samtsov, Mihail Yu. Krasavin, A. V. Garabagiou |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
State Scientific Center of Dermatovenereology and Cosmetology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f28238201e641e1bf37155624168e33 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perspective trends of topical therapy of patients with psoriasis
por: Alexander S. Zhukov, et al.
Publicado: (2021) -
THE ROLE OF CYTOKINES OF INTERLEUKIN 36 FAMILY IN IMMUNOPATHOGENESIS OF PSORIASIS
por: A. Yu. Pashkin, et al.
Publicado: (2018) -
Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation
por: Timo Burster, et al.
Publicado: (2021) -
The serine protease inhibitors and plant-insect interaction
por: Mendoza-Blanco,Werner, et al.
Publicado: (2012) -
Psoriasis
por: MOLL LEE,NORMAN
Publicado: (1947)